Your browser doesn't support javascript.
loading
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study.
Thom, Ruth; Tipton, Thomas; Strecker, Thomas; Hall, Yper; Akoi Bore, Joseph; Maes, Piet; Raymond Koundouno, Fara; Fehling, Sarah Katharina; Krähling, Verena; Steeds, Kimberley; Varghese, Anitha; Bailey, Graham; Matheson, Mary; Kouyate, Saidou; Coné, Moussa; Moussa Keita, Balla; Kouyate, Sekou; Richard Ablam, Amento; Laenen, Lies; Vergote, Valentijn; Guiver, Malcolm; Timothy, Joseph; Atkinson, Barry; Ottowell, Lisa; Richards, Kevin S; Bosworth, Andrew; Longet, Stephanie; Mellors, Jack; Pannetier, Delphine; Duraffour, Sophie; Muñoz-Fontela, César; Sow, Oumou; Koivogui, Lamine; Newman, Edmund; Becker, Stephan; Sprecher, Armand; Raoul, Herve; Hiscox, Julian; Henao-Restrepo, Ana Maria; Sakoba, Keita; Magassouba, N'Faly; Günther, Stephan; Kader Konde, Mandy; Carroll, Miles W.
Afiliação
  • Thom R; National Infection Service, Public Health England, Porton Down, UK.
  • Tipton T; National Infection Service, Public Health England, Porton Down, UK.
  • Strecker T; Institute of Virology, Philipps University of Marburg, Marburg, Germany.
  • Hall Y; National Infection Service, Public Health England, Porton Down, UK.
  • Akoi Bore J; Center for Training and Research on Priority Diseases including Malaria in Guinea, Conakry, Guinea; Ministry of Health Guinea, Conakry, Guinea.
  • Maes P; Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
  • Raymond Koundouno F; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Ministry of Health Guinea, Conakry, Guinea.
  • Fehling SK; Institute of Virology, Philipps University of Marburg, Marburg, Germany.
  • Krähling V; Institute of Virology, Philipps University of Marburg, Marburg, Germany; German Center for Infection Research, Partner Site Gießen-Marburg-Langen, Marburg, Germany.
  • Steeds K; National Infection Service, Public Health England, Porton Down, UK.
  • Varghese A; National Infection Service, Public Health England, Porton Down, UK.
  • Bailey G; Biodiscovery Institute, School of Medicine, University of Nottingham, UK.
  • Matheson M; National Infection Service, Public Health England, Porton Down, UK.
  • Kouyate S; Center for Training and Research on Priority Diseases including Malaria in Guinea, Conakry, Guinea.
  • Coné M; Center for Training and Research on Priority Diseases including Malaria in Guinea, Conakry, Guinea.
  • Moussa Keita B; Center for Training and Research on Priority Diseases including Malaria in Guinea, Conakry, Guinea.
  • Kouyate S; Center for Training and Research on Priority Diseases including Malaria in Guinea, Conakry, Guinea.
  • Richard Ablam A; Center for Training and Research on Priority Diseases including Malaria in Guinea, Conakry, Guinea.
  • Laenen L; Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
  • Vergote V; Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
  • Guiver M; Public Health Laboratory, National Infection Service, Public Health England, Manchester Royal Infirmary, Manchester, UK.
  • Timothy J; Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK.
  • Atkinson B; National Infection Service, Public Health England, Porton Down, UK.
  • Ottowell L; National Infection Service, Public Health England, Porton Down, UK.
  • Richards KS; National Infection Service, Public Health England, Porton Down, UK.
  • Bosworth A; National Infection Service, Public Health England, Porton Down, UK.
  • Longet S; National Infection Service, Public Health England, Porton Down, UK.
  • Mellors J; National Infection Service, Public Health England, Porton Down, UK; Department of Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
  • Pannetier D; P4 Jean Mérieux-Inserm Laboratory, Lyon, France.
  • Duraffour S; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
  • Muñoz-Fontela C; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
  • Sow O; National Ethics Committee for Health Research, Conakry, Guinea.
  • Koivogui L; Ministry of Health Guinea, Conakry, Guinea.
  • Newman E; National Infection Service, Public Health England, Porton Down, UK.
  • Becker S; Institute of Virology, Philipps University of Marburg, Marburg, Germany; German Center for Infection Research, Partner Site Gießen-Marburg-Langen, Marburg, Germany.
  • Sprecher A; Medecins San Frontieres Brussels, Brussels, Belgium.
  • Raoul H; P4 Jean Mérieux-Inserm Laboratory, Lyon, France.
  • Hiscox J; Department of Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
  • Henao-Restrepo AM; World Health Organization, Geneva, Switzerland.
  • Sakoba K; Projet Laboratoire Fièvres Hémorragiques, Conakry, Guinea.
  • Magassouba N; Projet Laboratoire Fièvres Hémorragiques, Conakry, Guinea.
  • Günther S; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
  • Kader Konde M; Center for Training and Research on Priority Diseases including Malaria in Guinea, Conakry, Guinea.
  • Carroll MW; National Infection Service, Public Health England, Porton Down, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK. Electronic address: miles.carroll@phe.gov.uk.
Lancet Infect Dis ; 21(4): 507-516, 2021 04.
Article em En | MEDLINE | ID: mdl-33065039

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Sobreviventes / Doença pelo Vírus Ebola / Ebolavirus / Anticorpos Antivirais Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn País como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Sobreviventes / Doença pelo Vírus Ebola / Ebolavirus / Anticorpos Antivirais Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn País como assunto: Africa Idioma: En Ano de publicação: 2021 Tipo de documento: Article